R2 Technology, Inc., Files Patent Infringement Suit Against ISSI Corporation.Business Editors SUNNYVALE, Calif.--(BUSINESS WIRE)--June 4, 2002 R2 Technology, Inc., a leader in computer aided detection (CAD) and visualization, announced that it has filed a patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. lawsuit against Intelligent Systems Software, Inc. (ISSI ISSI International Space Science Institute ISSI Inter-Switching System Interface ISSI International Society for Self and Identity ISSI International Society for Skin Imaging (Bochum, Germany) ISSI Internet Security Systems Inc. ), located in Boca Raton, Florida Boca Raton ("bōkə rə-tōn") is a city in Palm Beach County, Florida incorporated in May 1925. As of the 2000 census, the city had a total population of 74,764; the 2006 population recorded by the U.S. Census Bureau was 86,396. . A formal complaint filed yesterday by R2 in the U.S. District Court for the District of Delaware charges ISSI with infringing R2's U.S. Patent No. 6,198,838 B1, entitled "Method and System for Detection of Suspicious Lesions in Digital Mammograms Using a Combination of Spiculation spic·u·la·tion n. Formation into a spicule or spicules. and Density Signals"; U.S. Patent No. 5,729,620, entitled "Computer-Aided Diagnosis System and Method"; and U.S. Patent No. 5,917,929, entitled "User Interface For Computer Aided Diagnosis System." These patents address the ways in which R2's products scan, process and display images. "R2 welcomes competition in the area of computer aided detection. We believe fair competition is healthy and benefits the nations' providers, as well as consumers of healthcare services," said Mike Klein, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , R2 Technology. "However, R2 has a significant investment in breakthrough technology designed to help detect cancer earlier. As a result, R2 intends to vigorously protect its intellectual property and fully enforce its patent rights against any form of infringement. "During our nine years of development and four years of commercial sales, we have diligently protected and expanded our intellectual property position with exclusive and accessible patents. R2 currently owns or has rights to more than 85 U.S. patents and patent applications." R2's ImageChecker system was originally approved by the U.S. Food & Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) in 1998 for use with film-based screening mammography mammography, diagnostic procedure that uses low-dose X rays to detect abnormalities in the breasts. The early diagnosis of breast cancer made possible by the routine use of mammography for screening women increases a woman's treatment alternatives and improves her to assist radiologists in minimizing false negative readings. In 2001 the FDA expanded approval to include use of R2's ImageChecker with diagnostic mammograms and in April 2002, the FDA granted clearance for the use of R2's proprietary mammography CAD technology with the GE Senographe(R) full field digital mammography digital mammography Imaging The capture of mammographic images on a digital grid Pros ↑ resolution and clarity than conventional mammography; DM is of use as a screening technique, and allows faster, earlier, and more accurate detection of early breast (FFDM FFDM Full Field Digital Mammography FFDM Failed Fuel Dismantling Machine ) system. About R2 Technology, Inc. R2 Technology, Inc., headquartered in Sunnyvale, Calif., is a recognized leader in the development and commercialization of computer aided detection (CAD), an innovative technology that assists radiologists in the early detection of breast cancer and other cancer-related lesions. R2's CAD software has been integrated with the ImageChecker processing and visual display system, and is being successfully used by hospitals and imaging centers as an aid to radiologists for more accurate detection of breast cancer. To date, more than 400 film and digital-based ImageChecker systems have been shipped worldwide. As a medical software company, R2 is developing CAD systems for a variety of imaging modalities and disease states, including lung cancer. For more information, please visit www.r2tech.com. Note to Editors: ImageChecker is a registered trademark of R2 Technology, Inc. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion